Literature DB >> 16958852

Role of penicillin-binding protein 1b in competitive stationary-phase survival of Escherichia coli.

Evan D Pepper1, Michael J Farrell, Steven E Finkel.   

Abstract

The penicillin-binding proteins (PBPs) catalyze the synthesis and modification of bacterial cell wall peptidoglycan. Although the biochemical activities of these proteins have been determined in Escherichia coli, the physiological roles of many PBPs remain enigmatic. Previous studies have cast doubt on the individual importance of the majority of PBPs during log phase growth. We show here that PBP1b is vital for competitive survival of E. coli during extended stationary phase, but the other nine PBPs studied are dispensable. Loss of PBP1b leads to the stationary phase-specific competition defective phenotype and causes cells to become more sensitive to osmotic stress. Additionally, we present evidence that this protein, as well as AmpC, may assist in cellular resistance to beta-lactam antibiotics.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958852     DOI: 10.1111/j.1574-6968.2006.00418.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

1.  Evolution of penicillin-binding protein 2 concentration and cell shape during a long-term experiment with Escherichia coli.

Authors:  Nadège Philippe; Ludovic Pelosi; Richard E Lenski; Dominique Schneider
Journal:  J Bacteriol       Date:  2008-12-01       Impact factor: 3.490

2.  The El Tor biotype of Vibrio cholerae exhibits a growth advantage in the stationary phase in mixed cultures with the classical biotype.

Authors:  Subhra Pradhan; Amit K Baidya; Amalendu Ghosh; Kalidas Paul; Rukhsana Chowdhury
Journal:  J Bacteriol       Date:  2009-12-18       Impact factor: 3.490

3.  PBP1B Glycosyltransferase and Transpeptidase Activities Play Different Essential Roles during the De Novo Regeneration of Rod Morphology in Escherichia coli.

Authors:  Dev K Ranjit; Matthew A Jorgenson; Kevin D Young
Journal:  J Bacteriol       Date:  2017-03-14       Impact factor: 3.490

4.  Structural Insights into Inhibition of Escherichia coli Penicillin-binding Protein 1B.

Authors:  Dustin T King; Gregory A Wasney; Michael Nosella; Anita Fong; Natalie C J Strynadka
Journal:  J Biol Chem       Date:  2016-11-29       Impact factor: 5.157

5.  Mechanical Genomics Identifies Diverse Modulators of Bacterial Cell Stiffness.

Authors:  George K Auer; Timothy K Lee; Manohary Rajendram; Spencer Cesar; Amanda Miguel; Kerwyn Casey Huang; Douglas B Weibel
Journal:  Cell Syst       Date:  2016-06-16       Impact factor: 10.304

6.  Differential requirement for PBP1a and PBP1b in in vivo and in vitro fitness of Vibrio cholerae.

Authors:  Tobias Dörr; Andrea Möll; Michael C Chao; Felipe Cava; Hubert Lam; Brigid M Davis; Matthew K Waldor
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

7.  Cephem Potentiation by Inactivation of Nonessential Genes Involved in Cell Wall Biogenesis of β-Lactamase-Producing Escherichia coli.

Authors:  Kristin R Baker; Helga Høeg Sigurðardóttir; Bimal Jana; Luca Guardabassi
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

8.  Function and localization dynamics of bifunctional penicillin-binding proteins in Caulobacter crescentus.

Authors:  Wolfgang Strobel; Andrea Möll; Daniela Kiekebusch; Kathrin E Klein; Martin Thanbichler
Journal:  J Bacteriol       Date:  2014-02-14       Impact factor: 3.490

9.  Chimeric vaccine designs against Acinetobacter baumannii using pan genome and reverse vaccinology approaches.

Authors:  Fatima Shahid; Tahreem Zaheer; Shifa Tariq Ashraf; Muhammad Shehroz; Farha Anwer; Anam Naz; Amjad Ali
Journal:  Sci Rep       Date:  2021-06-24       Impact factor: 4.379

10.  Sub-inhibitory cefsulodin sensitization of E. coli to β-lactams is mediated by PBP1b inhibition.

Authors:  Sujoy K Sarkar; Mouparna Dutta; Akash Kumar; Dhriti Mallik; Anindya S Ghosh
Journal:  PLoS One       Date:  2012-11-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.